A Phase 2, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With HER2+ AR+ Metastatic or Locally Advanced Breast Cancer

Name: A Phase 2, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With HER2+ AR+ Metastatic or Locally Advanced Breast Cancer
Creator: Vivli
Published: 2025-11-13T18:21:50+08:00

DataCite Commons2025-11-14 更新2026-05-07 收录

癌症靶向治疗

临床评估

数据链接：

https://search.vivli.org/doiLanding/studies/PR00011949/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study was to evaluate the efficacy of enzalutamide with trastuzumab in patients with HER2+ AR+ metastatic or locally advanced breast cancer.

提供机构：

Vivli

创建时间：

2025-11-13